Abstract:Abstract Background The transplantation of neural stem/progenitor cells (NS/PCs) at the sub-acute phase of spinal cord injury, but not at the chronic phase, can promote functional recovery. However, the reasons for this difference and whether it involves the survival and/or fate of grafted cells under these two conditions remain unclear. To address this question, NS/PC transplantation was performed after contusive spinal cord injury in adult mice at the sub-acute and chronic phases. Results Quantitative analyses using bio-imaging, which can noninvasively detect surviving grafted cells in living animals, revealed no significant difference in the survival rate of grafted cells between the sub-acute and chronic transplantation groups. Additionally, immunohistology revealed no significant difference in the differentiation phenotypes of grafted cells between the two groups. Microarray analysis revealed no significant differences in the expression of genes encoding inflammatory cytokines or growth factors, which affect the survival and/or fate of grafted cells, in the injured spinal cord between the sub-acute and chronic phases. By contrast, the distribution of chronically grafted NS/PCs was restricted compared to NS/PCs grafted at the sub-acute phase because a more prominent glial scar located around the lesion epicenter enclosed the grafted cells. Furthermore, microarray and histological analysis revealed that the infiltration of macrophages, especially M2 macrophages, which have anti-inflammatory role, was significantly higher at the sub-acute phase than the chronic phase. Ultimately, NS/PCs that were transplanted in the sub-acute phase, but not the chronic phase, promoted functional recovery compared with the vehicle control group. Conclusions The extent of glial scar formation and the characteristics of inflammation is the most remarkable difference in the injured spinal cord microenvironment between the sub-acute and chronic phases. To achieve functional recovery by NS/PC transplantation in cases at the chronic phase, modification of the microenvironment of the injured spinal cord focusing on glial scar formation and inflammatory phenotype should be considered.

A Narrative Review of Advances in Neural Precursor Cell Transplantation Therapies for Spinal Cord Injury

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Strategies and Prospects of Effective Neural Circuits Reconstruction after Spinal Cord Injury

Cell therapy for spinal cord injury using induced pluripotent stem cells

Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives

Current status and prospects of regenerative medicine for spinal cord injury using human induced pluripotent stem cells: a review

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Spinal cord tissue engineering using human primary neural progenitor cells and astrocytes

Transplantation of PSA-NCAM-Positive Neural Precursors from Human Embryonic Stem Cells Promotes Functional Recovery in an Animal Model of Spinal Cord Injury

Improving Efficiency of Direct Pro-Neural Reprogramming: Much-Needed Aid for Neuroregeneration in Spinal Cord Injury

Combinatorial strategies for cell transplantation in traumatic spinal cord injury

Schwann Cell Transplantation for Spinal Cord Injury Repair: Its Significant Therapeutic Potential and Prospectus

Cell Transplantation and Neuroengineering Approach for Spinal Cord Injury Treatment: A Summary of Current Laboratory Findings and Review of Literature

Repair of the Injured Spinal Cord by Schwann Cell Transplantation

Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation

Evaluation of Benefits and Risks of Immunosuppressive Drugs in Biomaterial-Based Neural Progenitor Cell Transplantation for Spinal Cord Injury Repair

Human stem cell-derived neurons and neural circuitry therapeutics: Next frontier in spinal cord injury repair